Menu Close

New possibilities for prostate cancer treatment

Researchers have identified a sub-group of cells that could contribute to prostate cancer recurrence, a disease which claims more than 3,000 lives a year in Australia.

The newly identified cells are potential targets for future treatments as they are present early in disease development. There’s now a possibility of therapy before the cancer reaches the aggressive, incurable stage.

Prostate cancer is the most common form of cancer in men, with around 20,000 new cases diagnosed each year in Australia.

Read more at Monash University

Want to write?

Write an article and join a growing community of more than 180,900 academics and researchers from 4,919 institutions.

Register now